These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 286100)
1. A tumor-associated organ-specific antigen characteristic of spontaneously metastatic rat mammary carcinomas. Ghosh SK; Grossberg AL; Kim U; Pressman D J Natl Cancer Inst; 1979 May; 62(5):1229-33. PubMed ID: 286100 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas. North SM; Steck PA; Nicolson GL Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen B. Sleeman JP; Kim U; LePendu J; Howells N; Coquerelle T; Ponta H; Herrlich P Oncogene; 1999 Aug; 18(31):4485-94. PubMed ID: 10442639 [TBL] [Abstract][Full Text] [Related]
4. Ganglioside profiles of metastases and of metastasizing and nonmetastasizing rat primary mammary carcinomas. Skipski VP; Carter SP; Terebus-Kekish OI; Podlaski FJ; Peterson RH; Stock CC J Natl Cancer Inst; 1981 Dec; 67(6):1251-8. PubMed ID: 6947108 [TBL] [Abstract][Full Text] [Related]
5. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies. Nicolson GL; Lembo TM; Welch DR Cancer Res; 1988 Jan; 48(2):399-404. PubMed ID: 2825974 [TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
7. Lack of production of myoepithelial variants by cloned epithelial cell lines derived from the TMT-081 metastasizing rat mammary tumor. Dunnington DJ; Kim U; Hughes CM; Monaghan P; Rudland PS Cancer Res; 1984 Nov; 44(11):5338-46. PubMed ID: 6488188 [TBL] [Abstract][Full Text] [Related]
8. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies. Rapp L; Fuji H Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755 [TBL] [Abstract][Full Text] [Related]
9. Presence of a specific immune complex in the cell-free ascites of a spontaneously metastasizing rat mammary adenocarcinoma, TMT-081. Ghosh SK; Roholt OA Immunol Commun; 1984; 13(1):63-76. PubMed ID: 6735434 [TBL] [Abstract][Full Text] [Related]
10. Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas and a chemically induced mammary carcinoma in rats. Ankerst J; Steele G; Sjögren HO Cancer Res; 1974 Aug; 34(8):1794-800. PubMed ID: 4367178 [No Abstract] [Full Text] [Related]
11. Loss of myoepithelial cell characteristics in metastasizing rat mammary tumors relative to their nonmetastasizing counterparts. Dunnington DJ; Kim U; Hughes CM; Monaghan P; Ormerod EJ; Rudland PS J Natl Cancer Inst; 1984 Feb; 72(2):455-66. PubMed ID: 6198552 [TBL] [Abstract][Full Text] [Related]
12. Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas. Steele G; Sjögren HO Cancer Res; 1974 Aug; 34(8):1801-7. PubMed ID: 4366501 [No Abstract] [Full Text] [Related]
13. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma. Hoon DB; Ziola B; Ramshaw I Cancer Res; 1984 Jun; 44(6):2406-9. PubMed ID: 6722781 [TBL] [Abstract][Full Text] [Related]
14. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of prolactin on expression of Ia antigen by tumor cells. Bernard DJ; Maurizis JC; Chassagne J; Chollet P; Plagne R J Natl Cancer Inst; 1986 Jun; 76(6):1237-42. PubMed ID: 3012179 [TBL] [Abstract][Full Text] [Related]
15. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice. Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086 [TBL] [Abstract][Full Text] [Related]
16. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Chen WR; Liu H; Ritchey JW; Bartels KE; Lucroy MD; Nordquist RE Cancer Res; 2002 Aug; 62(15):4295-9. PubMed ID: 12154032 [TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages of mouse mammary tumors. II. Differential distribution of macrophages from metastatic and nonmetastatic tumors. Mahoney KH; Fulton AM; Heppner GH J Immunol; 1983 Oct; 131(4):2079-85. PubMed ID: 6311907 [TBL] [Abstract][Full Text] [Related]
18. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts. Krueger JG; Segal RA; Moyer RC Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and characteristics of spontaneously metastasizing mammary carcinomas and the general principle of metastasis. Kim U J Surg Oncol; 1986 Nov; 33(3):151-65. PubMed ID: 3095592 [TBL] [Abstract][Full Text] [Related]
20. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays. Lopez PF; Parks WP; Lopez DM J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]